TD-VK619016

Lenvervimab(TD-VK619016) is a research-grade recombinant antibody targetingLarge envelope protein. Produced in mammalian cells with native-like glycosylation.HighlightsResearch Grade— For PK/PD studies, assay development, and ADA research.Native Glycosylation— Mammalian expression ensures native-like patterns.

Hepatitis B virus genotype A (HBV-A)

ELISA, Bioactivity: FACS, Functional assay, Research in vivo

Humanized

IgG1, kappa

Monoclonal

Large envelope protein, L glycoprotein, L-HBsAg, LHB, Large S protein, Large surface protein, Major surface antigen, S

Please contact the lab for this information.

>95% purity as determined by SDS-PAGE.

Protein A/G purified from cell culture supernatant.

P03142-3

Liquid

0.01M PBS, pH 7.4.Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.

GC-1102, 2055006-79-4

Lenvervimab (GC1102) is a IgG1-type recombinant human hepatitis B Immunoglobulin. Lenvervimab can be used for research of hepatitis B virus infection.

SDS-PAGE for Research Grade Lenvervimab　　|　Flow-cytometry using PE anti-human RSF1 antibody. K562 cells were fixed and permeabilized, then stained with an irrelevant antibody (Blue Histogram) or an PE anti-human RSF1 monoclonal antibody (Catalog VK619016, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer. ### Flow-cytometry using FITC anti-human RSF1 antibody. K562 cells were fixed and permeabilized, then stained with an irrelevant antibody (Blue Histogram) or an FITC anti-human RSF1 monoclonal antibody (Catalog VK619016, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

For research use only. Not suitable for clinical or therapeutic use.